Enzymes Incorporated – Trademark Portfolio

Entity Type: 03

Enzymes Incorporated holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include VWA and DISCOVER THE ENZYME. The owner is based in Wauconda, IL.

Unit 102

1099 Brown Street

Wauconda, IL 60084

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Enzymes Incorporated's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (5 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Enzymes Incorporated have?

Enzymes Incorporated has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 cancelled.

What trademark classes does Enzymes Incorporated file in?

Enzymes Incorporated files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 1 (Chemicals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Enzymes Incorporated's most well-known trademarks?

Enzymes Incorporated's registered trademark portfolio includes well-known marks such as VWA and DISCOVER THE ENZYME. These are among 2 currently registered trademarks in the portfolio.

What is Enzymes Incorporated's trademark registration success rate?

Enzymes Incorporated has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.